Evidence of a novel docetaxel sensitizer
β
Edward W. Howard; Davy T. Lee; Yung Tuen Chiu; Chee Wai Chua; Xianghong Wang; Yo
π
Article
π
2008
π
John Wiley and Sons
π
French
β 770 KB
## Abstract The recent introduction of docetaxel in the treatment of hormone refractory prostate cancer (HRPC) has made a small but significant impact on patient survival. However, its effect is limited by intolerance and resistance. The aim of our study was to investigate if the garlicβderived com